| Stephen B Siegel, M D | |
|
2750 Broadway St, Boulder, CO 80304-3573 | |
| (303) 440-3093 | |
| (303) 440-3161 |
| Full Name | Stephen B Siegel |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 31 Years |
| Location | 2750 Broadway St, Boulder, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902860091 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 040149 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Boulder Community Health | Boulder, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boulder Medical Center, Pc | 4183536204 | 79 |
News Archive
Corin, a global orthopedic manufacturer and leader in functional implant positioning, today announced the launch of the Trinity Dual Mobility System featuring new implant technology designed to improve range of motion and reduce the risk for instability and dislocation after primary or revision hip replacement.
Because the incidence of malignant melanoma is rising faster than any other cancer in the U.S., researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues at Tampa-based Intezyne Technologies, Inc., Western Carolina University and the University of Arizona are working overtime to develop new technologies to aid in both malignant melanoma diagnosis and therapy.
AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of live cellular bone growth substitutes, today announced its receipt of the Foothills Award from Colorado Performance Excellence (CPEx), a statewide non-profit that helps organizations improve performance and achieve results.
An investigation undertaken by Novozymes Biopharma DK has shown that when the corticosteroid dexamethasone is formulated in a cross-linked Hyaluronic acid (HA) hydrogel, the drug's in vitro release time increases from under 10 minutes to approximately 15 hours. In addition, the in vivo half-life of dexamethasone is shown to plateau with stable dexamethasone concentration up to four hours after injection.
› Verified 6 days ago
| Entity Name | Boulder Medical Center, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306820923 PECOS PAC ID: 4183536204 Enrollment ID: O20031105000512 |
News Archive
Corin, a global orthopedic manufacturer and leader in functional implant positioning, today announced the launch of the Trinity Dual Mobility System featuring new implant technology designed to improve range of motion and reduce the risk for instability and dislocation after primary or revision hip replacement.
Because the incidence of malignant melanoma is rising faster than any other cancer in the U.S., researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues at Tampa-based Intezyne Technologies, Inc., Western Carolina University and the University of Arizona are working overtime to develop new technologies to aid in both malignant melanoma diagnosis and therapy.
AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of live cellular bone growth substitutes, today announced its receipt of the Foothills Award from Colorado Performance Excellence (CPEx), a statewide non-profit that helps organizations improve performance and achieve results.
An investigation undertaken by Novozymes Biopharma DK has shown that when the corticosteroid dexamethasone is formulated in a cross-linked Hyaluronic acid (HA) hydrogel, the drug's in vitro release time increases from under 10 minutes to approximately 15 hours. In addition, the in vivo half-life of dexamethasone is shown to plateau with stable dexamethasone concentration up to four hours after injection.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen B Siegel, M D 1579 Straits Tpke, Suite 2a, Middlebury, CT 06762-1835 Ph: (203) 757-8361 | Stephen B Siegel, M D 2750 Broadway St, Boulder, CO 80304-3573 Ph: (303) 440-3093 |
News Archive
Corin, a global orthopedic manufacturer and leader in functional implant positioning, today announced the launch of the Trinity Dual Mobility System featuring new implant technology designed to improve range of motion and reduce the risk for instability and dislocation after primary or revision hip replacement.
Because the incidence of malignant melanoma is rising faster than any other cancer in the U.S., researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues at Tampa-based Intezyne Technologies, Inc., Western Carolina University and the University of Arizona are working overtime to develop new technologies to aid in both malignant melanoma diagnosis and therapy.
AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of live cellular bone growth substitutes, today announced its receipt of the Foothills Award from Colorado Performance Excellence (CPEx), a statewide non-profit that helps organizations improve performance and achieve results.
An investigation undertaken by Novozymes Biopharma DK has shown that when the corticosteroid dexamethasone is formulated in a cross-linked Hyaluronic acid (HA) hydrogel, the drug's in vitro release time increases from under 10 minutes to approximately 15 hours. In addition, the in vivo half-life of dexamethasone is shown to plateau with stable dexamethasone concentration up to four hours after injection.
› Verified 6 days ago
John Christopher Kefer, MD PHD Urology Medicare: Accepting Medicare Assignments Practice Location: 4743 Arapahoe Ave, Suite 104, Boulder, CO 80303 Phone: 303-444-9000 Fax: 303-444-9073 | |
Larry Croft Munch, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2750 Broadway St, Boulder, CO 80304 Phone: 303-440-3093 Fax: 303-440-3161 | |
Dr. Gordon T Matsuda, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 3434 47th St, Suite 101, Boulder, CO 80301 Phone: 303-444-0840 Fax: 303-444-0838 | |
Dr. John Christopher Webster, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4743 Arapahoe Ave, Boulder, CO 80303 Phone: 303-444-9000 Fax: 303-444-9073 |